
Apyx Medical Corporation APYX
$ 3.84
-1.03%
Annual report 2025
added 03-10-2026
Apyx Medical Corporation Total Non Current Liabilities 2011-2026 | APYX
Annual Total Non Current Liabilities Apyx Medical Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.1 M | 1.18 M | 140 K | 2.98 M | 3.62 M | 3.92 M | 16.4 M | 8.93 M | 3.37 M | 3.73 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.4 M | 140 K | 4.53 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
184 M | $ 184.69 | 2.23 % | $ 13.8 B | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
AxoGen
AXGN
|
1.61 M | $ 34.46 | 2.96 % | $ 1.59 B | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 12.77 | 3.65 % | $ 1.73 B | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 292.23 | 1.41 % | $ 8.24 B | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.59 | 0.67 % | $ 36.7 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.37 | 1.35 % | $ 126 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 39.9 | 2.18 % | $ 5.94 K | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 63.82 | 1.01 % | $ 94.5 B | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
52.5 M | $ 6.34 | -1.71 % | $ 169 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.03 | - | $ 17.4 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 10.38 | 3.7 % | $ 294 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
8.87 K | $ 25.21 | 1.47 % | $ 213 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
LENSAR
LNSR
|
3.44 M | $ 6.04 | 2.03 % | $ 72.2 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 94.94 | 2.11 % | $ 12.8 B | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 1.98 | -2.46 % | $ 1.2 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Myomo
MYO
|
275 K | $ 0.79 | 8.49 % | $ 33.1 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.86 | 5.37 % | $ 419 M | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 10.88 | 4.11 % | $ 390 M | ||
|
Inspire Medical Systems
INSP
|
24.6 M | $ 56.83 | 3.48 % | $ 1.67 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 39.73 | 3.3 % | $ 1.23 B | ||
|
LivaNova PLC
LIVN
|
516 M | $ 64.99 | 0.63 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
1.02 B | $ 88.63 | 1.03 % | $ 3.08 B | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.76 | 0.27 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 78.2 | 0.1 % | $ 45.7 B |